Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET/CT

Clinical Nuclear Medicine

Volumn 38, Issue 8, 2013, Pages 639-640

  Naswa, Niraj ^a   Sharma, Punit ^a   Kumar, Rakesh ^a   Malhotra, Arun ^a   Bal, Chandrasekhar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

68Ga DOTANOC; PET CT; Tumor induced osteomalacia

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; GALLIUM 68; PHOSPHATE;

ADULT; ARTICLE; BONE PAIN; CALLUS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; CASE REPORT; FIBULA; FRACTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHOSPHATEMIA; MALE; MINIMAL RESIDUAL DISEASE; MUSCLE WEAKNESS; ONCOGENIC OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; RARE DISEASE; REOPERATION;

HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM, RESIDUAL; ORGANOMETALLIC COMPOUNDS; OSTEOMALACIA; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880744802     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318279eb13     Document Type: Article

References (8)

1. Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med. 2000;41:1704-1713.
2. Cai Q, Hodgson SF, Kao PC, et al. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med. 1994;330:1645-1649.
3. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors: a polymorphus group causing osteomalacia or rickets. Cancer. 1987;59:1442-1454.
4. Brame LA, White KE, Econs MJ. Renal phosphate wasting disorders: clinical features and pathogenesis. Semin Nephrol. 2004;24:39-47.
5. Fukumoto S, Takeuchi Y, Nagano A, et al. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone. 1999;25:375-377.
6. Lamberts SWJ, van der Lely AJ, de Herder WW, et al. Octreotide. N Engl J Med. 1996;334:246-254.
7. Khadgawat R, Singh Y, Kansara S, et al. PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia. Singapore Med J. 2009;50:55-57.
8. Dupond JL, Mahammedi H, Prie D, et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case. Bone. 2005;36:375-378.